Novo Nordisk A/S: Hemostatic Disorders trials

The registry lists 104 Hemostatic Disorders studies with Novo Nordisk A/S as lead sponsor. 0 are open to participants now and 26 have results posted.

Phase 1 32Phase 2 20Phase 3 21Phase 4 4No phase 27(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

Trial of NovoSeven® in Haemophilia - Joint BleedsCompletedNCT00108797Phase 4
Efficacy of NovoSeven® in Bleeding Prophylaxis in HemophiliaCompletedNCT00108758Phase 2
Dose Response to Recombinant Factor VIIa When Administered for BleedCompletedNCT00104455Phase 1
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll DeficiencyCompletedNCT00056589Phase 1

All Hemostatic Disorders studies →Novo Nordisk A/S: all focus areas →